XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2022
Dec. 25, 2021
OPERATING ACTIVITIES    
Net income $ 187.4 $ 499.2
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 22.7 22.3
Amortization of acquired intangible assets 63.2 85.7
Stock-based compensation expense 20.5 18.7
Deferred income taxes (26.2) (21.9)
Debt extinguishment loss 0.0 0.7
Other adjustments and non-cash items 29.1 5.7
Changes in operating assets and liabilities, excluding the effect of acquisitions:    
Accounts receivable (45.0) (48.1)
Inventories (47.0) (17.4)
Prepaid income taxes 17.9 (4.6)
Prepaid expenses and other assets 26.2 0.3
Accounts payable 1.5 (13.8)
Accrued expenses and other liabilities 0.8 42.4
Deferred revenue 2.3 (5.0)
Net cash provided by operating activities 253.4 564.2
INVESTING ACTIVITIES    
Acquisition of businesses, net of cash acquired 0.0 (157.3)
Capital expenditures (15.8) (20.5)
Proceeds from the Department of Defense 0.0 21.3
Increase in equipment under customer usage agreements (13.3) (17.0)
Payments for (Proceeds from) Other Investing Activities (1.9) 0.0
Purchase of insurance contracts (10.0) 0.0
Net cash used in investing activities (41.0) (173.5)
FINANCING ACTIVITIES    
Proceeds from long-term debt, net of issuance costs 0.0 1,491.2
Repayment of long-term debt (3.8) (1,387.5)
Payment of deferred acquisition consideration (0.8) 0.0
Repayments of acquired long term debt 0.0 (63.6)
Repurchase of common stock (100.0) (167.0)
Proceeds from issuance of common stock pursuant to employee stock plans 15.1 6.4
Payment of minimum tax withholdings on net share settlements of equity awards (23.0) (22.4)
Payments under finance lease obligations (1.0) (0.6)
Net cash used in financing activities (113.5) (143.5)
Effect of exchange rate changes on cash and cash equivalents 2.9 3.3
Net increase in cash and cash equivalents 101.8 250.5
Cash and cash equivalents, beginning of period 2,339.5 1,170.3
Cash and cash equivalents, end of period $ 2,441.3 $ 1,420.8